Clinical Trial Grants

Clinical Trial Grants support Phase II/III clinical trials of novel, high-potential treatments for MND/ALS within the Australian Clinical Trials Consortium.   

These grants are awarded with an offer of up to AUD $1,800,000 (Phase II/III trial), with project performance of up to 3 years.  

Eligibility: Applications are open to MND/ALS researchers globally. Australian trial sites and participants are mandatory.

 Application Limits

Applicants are limited to THREE (3) applications per person in total as an investigator (Primary or Co-Investigator) across all research schemes (excluding Fellowships).  There is no restriction on grants as a collaborator    

Click here to download a copy of: 

• The Clinical Trial Grants Criteria 
• The manual on how to submit a Letter of Intent and a Full Application (if invited) for a Clinical Trial Grant using Fluxx 

Videos to guide your submission using the FightMND Grant Management System – Fluxx: 

• How to submit a Letter of Intent and a Full Application (if invited) for a Clinical Trial Grant using Fluxx